| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |